19.8 C
New York
Friday, July 4, 2025

Tag: SHM FVT

ADAR1 Issues Statement on Keros Therapeutics’ Troubling 2025 Director Election Results and Insufficient Capital Return Proposal

Significant Withhold Votes from Directors Mary Ann Gray and Alpna Seth Underscores Need for Change and a More Disciplined Capital Allocation Strategy AUSTIN, Texas, June...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSHM FVT